Poly Medicure Limited has scheduled one-on-one meetings with analysts and investors for August 27 and August 31, 2026. The engagements are part of the company’s ongoing disclosure obligations under SEBI regulations.

The company notified the Bombay Stock Exchange and the National Stock Exchange of India Limited regarding the schedule. These interactions aim to provide market participants with updates on the business, subject to regulatory guidelines.

Meeting Schedule

The management team will host two separate sessions during the latter half of August. One meeting is virtual, while the other will be held at the registered office in New Delhi.

Regulatory Compliance

The intimation was issued pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates timely disclosure of price-sensitive information to stock exchanges.

Avinash Chandra, Company Secretary, signed the communication. He confirmed that no unpublished price-sensitive information will be shared during these meetings. The schedule remains subject to change due to exigencies on the part of the analysts, investors, or the company.

Investors can access further details on the company’s website.

Poly Medicure has scheduled its 31st Annual General Meeting (AGM) for September 5, 2026. The company published a formal notice in a newspaper to inform shareholders of the upcoming event and the matters requiring their consideration.

The notice was digitally signed by Avinash Chandra on August 15, 2026, at 4:39 pm. The document serves as a statutory communication to ensure all equity shareholders are aware of the meeting date and the specific resolutions to be voted upon.

Agenda Details

The advertisement outlines the standard procedural items for the annual meeting. While the specific text of the resolutions is obscured in the provided draft, typical AGM agendas include the adoption of financial statements, appointment of auditors, and declaration of dividends if approved by the board.

Shareholders are expected to review these items during the meeting. The company must adhere to regulatory timelines for dispatching notices and holding the assembly as per the Companies Act requirements.

Corporate Governance

This filing represents a routine corporate governance obligation rather than a disclosure of operational or financial performance. Poly Medicure will likely release its quarterly or annual financial results separately through stock exchange filings.

Investors should monitor subsequent communications from the company for updates on revenue, profit, and strategic initiatives following the conclusion of the AGM.